(114 days)
Not Found
Not Found
No
The device description and performance studies focus on the physical properties, sterility, and biocompatibility of a disposable tissue culture dish, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No.
Explanation: The device is labware used to hold zygotes/embryos during micromanipulation and tissue culture procedures, not a device directly applied to a patient for diagnosis, treatment, or prevention of disease.
No
The NewLife Dish is a piece of labware (a dish) used to hold zygotes/embryos during micromanipulation and tissue culture procedures in an IVF laboratory. Its function is to facilitate procedures performed by embryologists, not to diagnose conditions or diseases. The performance studies described (mouse embryo toxicity and endotoxin levels) are quality control tests for the product itself, not diagnostic performance metrics.
No
The device description clearly states the device is fabricated from polystyrene and is a physical dish, indicating it is a hardware device, not software only.
Based on the provided information, the NewLife Dish is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use is to hold zygotes/embryos during micromanipulation or other tissue culture procedures in the IVF laboratory. It is a piece of labware used in a procedure, not a device that performs a diagnostic test on a sample from the human body.
- Device Description: It is described as disposable tissue culture labware made of polystyrene. This aligns with laboratory consumables, not diagnostic devices.
- Performance Studies: The performance studies focus on the dish's suitability for embryo culture (mouse embryo toxicity) and sterility, which are relevant for laboratory consumables used in sensitive procedures, but not for evaluating the accuracy or performance of a diagnostic test.
- Lack of Diagnostic Function: There is no mention of the device analyzing a sample, providing a result related to a disease or condition, or being used to make a diagnosis.
The NewLife Dish is a laboratory consumable used in the process of In Vitro Fertilization (IVF), which is a medical procedure. While it is essential for the IVF process, it does not fit the definition of an IVD, which is a device intended for use in vitro for the examination of specimens derived from the human body solely or principally for the purpose of providing information concerning a physiological or pathological state, or concerning a congenital abnormality, or to monitor therapeutic measures.
N/A
Intended Use / Indications for Use
The NewLife Dish's indication for use is to hold zygotes/embryos during micromanipulation or other tissue culture procedures in the IVF laboratory.
NewLife Dishes are used in the tissue culture techniques performed by embryologists when injecting a single sperm into an egg, or assisting an embryo in hatching prior to re-implantation.
The dishes are disposable tissue culture labware used in procedures that have been developed to aid infertile couples achieve pregnancy. Specifically, the ICSI procedure is beneficial in cases where the male infertility is impaired.
Product codes
85 MQK
Device Description
NewLife Dishes are fabricated from polysterene and are 60 mm. diameter. Dishes are made with or without clear lids, etched or unetched. Etched dishes have a center circle with 8 smaller circles inside the larger circle, and a 9th circle inside the 8 circles. There are numbers 1 through 8 outside the large circle, with the number 1 at the top of the dish. Unetched dishes have center circles, but no other circles are etched on the dishes. Dishes are disposable, intended for one time use only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Embryologists in the IVF laboratory.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Description of Testing Procedures:
Each lot of New Life dishes is mouse embryo tested for toxicity. We use a two-cell mouse embryo bioassay. A two-cell mouse embryo test was performed as follows: 25 ul tissue culture medium containing serum albumin and penicillin/streptomycin was overlaid with 1 ml mineral oil and equilibrated overnight in 5.5% CO2. On the morning of the embryo harvest, medium was exposed to product and embryos were cultured in the media beginning at the two-cell stage. For NewLife Dishes, the MEA is performed in the test dish, providing continuous exposure. Control droplets of medium were not exposed to product before receiving embryos. The combined percent of embryos developing to expanded and/or hatching blastocysts were assessed at 72 hours of culture. Embryos exposed to the dishes are considered nontoxic if the number of expanded and/or hatching blastocysts in the treated group is within 10% of the control group, and no contamination of the culture has occurred. Greater than 80% hatching/expanded blastoycysts in the control group indicates a valid assay.
Each lot of dishes is also tested for endotoxin levels using the Limulus Amebocyte Lysate assay. The level of endotoxin units per device must be less than 20 to be considered acceptable.
Each lot of dishes is sterilized by gamma radiation with a sterility assurance level of 106. Quarterly dose audits are performed to insure the sterility assurance level is maintained or following each batch sterilization if less often than quarterly.
The packaging to maintain device sterility consists of a pouch made from INTEGRA® Peel K packaging. This is a reinforced, heavy-weight 70 lb. paper coated with a sealant, designed for medical device packaging applications. The package is heat-sealed. This packaging has been tested to ensure a microbial barrier, and has been validated to maintain sterility for a shelf life of 2 years.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Upon the effective date, the Federal Register document may be cited in the absence of an existing predicate device which would be used to support substantial equivalence.
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 884.6160 Assisted reproduction labware.
(a)
Identification. Assisted reproduction labware consists of laboratory equipment or supplies intended to prepare, store, manipulate, or transfer human gametes or embryos for in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), or other assisted reproduction procedures. These include syringes, IVF tissue culture dishes, IVF tissue culture plates, pipette tips, dishes, plates, and other vessels that come into physical contact with gametes, embryos or tissue culture media.(b)
Classification. Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, and clinical testing). The device, when it is a dish or plate intended for general assisted reproduction technology procedures, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.
0
12990941
510(k) SUMMARY
Submitter's Name: Humagen Fertility Diagnostics, Inc.
Address: 2400 Hunter's Way Charlottesville, VA 22911
Telephone #: (804) 979-4000
FAX #: (804) 295-5912
Contact person: Cindy Showalter
Date summary prepared: May 28, 1999
1
Device name:
Classification name: Assisted reproduction labware (per CFR# 884.6160)
Common/Usual name: ICSI Tissue Culture Dish
NewLife™ Dish Proprietary names:
Substantial Equivalence:
Substantial equivalence is being supported by the Federal Register Notice Final Rule entitled "Obstetric and Gynecologic Devices; Reclassification and Classification of Medical Devices Used for In Vitro Fertilization and Related Assisted Reproduction Procedures. This equivalence is supported by the SUMMARY statement:
Upon the effective date, the Federal Register document may be cited in the absence of an existing predicate device which would be used to support substantial equivalence.
Description of Device:
NewLife Dishes are fabricated from polysterene and are 60 mm. diameter. Dishes are made with or without clear lids, etched or unetched. Etched dishes have a center circle with 8 smaller circles inside the larger circle, and a 9th circle inside the 8 circles. There are numbers 1 through 8 outside the large circle, with the number 1 at the top of the dish. Unetched dishes have center circles, but no other circles are etched on the dishes. Dishes are disposable, intended for one time use only.
Testing Procedures:
Each lot of New Life dishes is mouse embryo tested for toxicity. We use a two-cell mouse embryo bioassay. A two-cell mouse embryo test was performed as follows: 25 ul tissue culture medium containing serum albumin and penicillin/streptomycin was overlaid with 1 ml mineral oil and equilibrated overnight in 5.5% CO2. On the morning of the embryo harvest, medium was exposed to product and embryos were cultured in the media beginning at the two-cell stage. For NewLife Dishes, the MEA is performed in the test dish, providing continuous exposure. Control droplets of medium were not exposed to product before receiving embryos. The combined percent of embryos developing to expanded and/or hatching blastocysts were assessed at 72 hours of culture. Embryos exposed to the dishes are considered nontoxic if the number of expanded and/or hatching blastocysts in the treated group is within 10% of the control group, and no contamination of the culture
2
has occurred. Greater than 80% hatching/expanded blastoycysts in the control group indicates a valid assay.
Each lot of dishes is also tested for endotoxin levels using the Limulus Amebocyte Lysate assay. The level of endotoxin units per device must be less than 20 to be considered acceptable.
Each lot of dishes is sterilized by gamma radiation with a sterility assurance level of 106. Quarterly dose audits are performed to insure the sterility assurance level is maintained or following each batch sterilization if less often than quarterly.
The packaging to maintain device sterility consists of a pouch made from INTEGRA® Peel K packaging. This is a reinforced, heavy-weight 70 lb. paper coated with a sealant, designed for medical device packaging applications. The package is heat-sealed. This packaging has been tested to ensure a microbial barrier, and has been validated to maintain sterility for a shelf life of 2 years.
Intended use statement:
The NewLife Dish's intended use is to hold zygotes/embryos during micromanipulation or other tissue culture procedures in the IVF laboratory.
New Life Dishes are used in the tissue culture techniques performed by embryologists when injecting a single sperm into an egg, or assisting an embryo in hatching prior to reimplantation.
The dishes are disposable tissue culture labware used in procedures that have been developed to aid infertile couples achieve pregnancy. Specifically, the ICSI procedure is beneficial in cases where the male infertility is impaired.
3
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus, which is a symbol of medicine and health. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES" are arranged in a circular pattern around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 14 1999
Ms. Cindy Showalter Quality Assurance Manager Humagen Fertility Diagnostics, Inc. 2400 Hunter's Way Charlottesville, VA 22911
Re: K990941 Newlife Dish Dated: May 31, 1999 Received: June 2, 1999 Regulatory Class: II 21 CFR §884.6160/Procode: 85 MQK
Dear Ms. Showalter:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compilance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also. please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
| 510 (k) NUMBER (IF KNOWN) : | KG90941 |
|---|---|
| DEVICE NAME: | NewLife Dish |
INDICATIONS FOR USE:
The NewLife Dish s indication for use is to hold zygotes/embryos during micromanipulation or other tissue culture procedures in the IVF laboratory.
NewLife Dishes are used in the tissue culture techniques performed by embryologists when injecting a single sperm into an egg, or assisting an embryo in hatching prior to re-implantation.
The dishes are disposable tissue culture labware used in procedures that have been developed to aid infertile couples achieve pregnancy. Specifically, the ICSI procedure is beneficial in cases where the male infertility is impaired.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
Prescription Use (Per 21 CFR 801.109)
ાર
Over-The-Counter-Use (Optional Format 1-2-96)
Rati Palys
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological
510(k) Number